Janssen, Bayer to close South Korean plants due to limited demand Janssen and Bayer are joining a long list of pharma companies closing their manufacturing facilities in South Korea. And […]
Allergan preludes major selloffs with 0M Almirall dermatology sale Allergan, which is shopping assets to help turn its stock price around, has taken its first small step into selloff land. […]
Thomas Hughes leaves Zafgen to take CEO role at Navitor Thomas Hughes, Ph.D., has left Zafgen to become CEO at mTORC1 startup Navitor Pharmaceuticals. Hughes helmed Zafgen through a turbulent […]
CAR-T player Cellectis poaches Stefan Scherer from Novartis Cellectis has named Stefan Scherer, M.D., Ph.D., as its SVP of clinical development. Scherer joins the off-the-shelf CAR-T pioneer from Novartis, where […]
Fortress Bio’s in-house stockbrokers raised 0M to support its young biotechs: Reuters Fortress Biotech used its own, in-house brokerage firm, National Securities, to raise at least $240 million from thousands […]